Author:
Colombo Nicoletta,Conte Pier Franco,Pignata Sandro,Raspagliesi Francesco,Scambia Giovanni
Reference96 articles.
1. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J. Clin. Oncol.,2012
2. Independent radiologic review: bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer;Aghajanian;Gynecol. Oncol.,2014
3. Final analysis of overall survival in OCEANS, a randomized phase III trial of gemcitabine, carboplatin, and bevacizumab followed by bevacizumab until disease progression in patients with platinum-sensitive recurrent ovarian cancer;Aghajanian,2014
4. Lymphangiogenesis in development and human disease;Alitalo;Nature,2005
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献